Influences on CHD incidence and case fatality: medical management of risk factors

T A Pearson1

  • 1Research Institute, Mary Imogene Bassett Hospital, Cooperstown, New York 13326.

Insights

Medical management of hypertension and hyperlipidemia shows potential for reducing coronary heart disease (CHD) mortality. However, current data suggest a minor impact on international CHD trends, with more research needed.

Area of Science:

  • Cardiovascular Epidemiology
  • Public Health Interventions
  • Medical Risk Factor Management

Background:

  • International trends in coronary heart disease (CHD) mortality are influenced by various risk factors.
  • Hypertension, hypercholesterolaemia, and smoking are key modifiable risk factors for CHD.
  • Limited organized international data exist to correlate risk factor management with CHD mortality trends.

Purpose of the Study:

  • To review the role of medical management of risk factors in explaining international CHD mortality trends.
  • To assess the impact of interventions for hypertension, hypercholesterolaemia, and smoking on CHD.
  • To identify areas for future research in risk factor detection and management.

Main Methods:

  • Review of existing international data on CHD mortality and risk factor management.
  • Analysis of trends in hypertension detection and control rates globally.
  • Evaluation of the impact of medical interventions for hyperlipidaemia and smoking cessation.

Main Results:

  • Hypertension detection and control are improving but remain low in many countries.
  • Medical management of hyperlipidaemia is a recent development, unlikely to explain past CHD trends.
  • The impact of medical systems on smoking cessation is unclear but holds significant potential.

Conclusions:

  • Medical management of risk factors has had a minor impact on international CHD mortality trends to date.
  • Improved blood pressure control may have contributed to observed CHD mortality trends.
  • Future research is crucial to better understand the role of risk factor management in reducing CHD mortality.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...